Gsk (GSK) Change in Taxes (2009 - 2026)

Gsk's Change in Taxes history runs 18 years deep, the most recent figure standing at -$281.8 million for Q1 2026.

• In Q1 2026, Change in Taxes fell 43.41% year-over-year to -$281.8 million; the TTM figure through Mar 2026 stood at -$2.0 billion (down 2.28% YoY), while the FY2025 annual figure was -$1.6 billion, up 5.14% from the prior year.
• Change in Taxes for Q1 2026 stood at -$281.8 million, up from -$655.8 million in the prior quarter.
• The five-year high for Change in Taxes was -$195.9 million in Q1 2022, with the low at -$904.9 million in Q4 2024.
• The 5-year median for Change in Taxes is -$284.4 million (2023), against an average of -$448.6 million.
• The sharpest annual moves came in 2023 and 2025: Change in Taxes slumped 45.19% in 2023, then gained 27.53% in 2025.
• Gsk's Change in Taxes stood at -$626.3 million in 2022, then decreased by 8.39% to -$678.9 million in 2023, then slumped by 33.28% to -$904.9 million in 2024, then climbed by 27.53% to -$655.8 million in 2025, then surged by 57.03% to -$281.8 million in 2026.
• Business Quant data shows GSK's Change in Taxes at -$281.8 million in Q1 2026, -$655.8 million in Q4 2025, and -$196.5 million in Q1 2025.